Rylee Key, Dyer County: Key had 15 kills in a 3-1 victory over McCracken County, and 14 kills in a 3-1 loss to Bowling Green. Kierstyn Ray, Dyer Co.: Ray had 39 assists against McCracken Co., and 36 ...

The next Steal a Fish admin abuse event starts on October 4 at 9:00 AM PT. The event runs for 90 minutes and offers rare fish, bonuses, and discounts. Steal a Fish admin abuse event is a limited-time ...

Genmab closed out a busy third quarter for M&A in biopharma, picking up cancer biotech Merus for $8 billion. This deal—the year’s fifth largest—came just a week after Pfizer acquired rising obesity ...

Emma Walmsley, the CEO who led the U.K. drugmaker GSK through the Covid-19 pandemic and the transformative spinoff of its consumer-health brands, will step down at the end of the year, the company ...

Rylee Key, Dyer County: Key had 15 kills in a 3-1 victory over McCracken County, and 14 kills in a 3-1 loss to Bowling Green. Kierstyn Ray, Dyer Co.: Ray had 39 assists against McCracken Co., and 36 ...

Emma Walmsley, the first woman to lead a big pharma company as CEO, will step down from that post Dec. 31, handing the reins of one of Britain’s premier drugmakers to commercial chief Luke Miels. In a ...

GSK plc announces its CEO transition, with CCO Luke Miels to succeed Emma Walmsley, as shares rise 3% and the company maintains a 4% dividend yield. GSK's strengths include its HIV, vaccines, and ...

Miels, GSK's chief commercial officer, to become CEO in January Miels joined GSK in 2017, bringing extensive biopharma experience GSK shares rise over 2% Sept 29 (Reuters) - GSK's (GSK.L), opens new ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026. He joined GSK in 2017 and is currently Chief ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Dame Emma Walmsley, CEO of GSK arrives for a ...

GSK named Luke Miels to succeed Emma Walmsley as the British drugmaker's chief executive at a pivotal time for the company. Under Walmsley, the U.K. pharmaceuticals giant reinvigorated its research ...